Cargando…
A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada
Canada needs a national strategy to fulfill its obligation to ensure universal access to necessary healthcare, including prescription drugs. A 2004 attempt at a national strategy for pharmaceutical policy failed because it lacked clear vision, logical planning and commitment from federal and provinc...
Autores principales: | Morgan, Steven G., Gagnon, Marc-André, Mintzes, Barbara, Lexchin, Joel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Longwoods Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008128/ https://www.ncbi.nlm.nih.gov/pubmed/27585023 |
Ejemplares similares
-
CETA and pharmaceuticals: impact of the trade agreement between Europe and Canada on the costs of prescription drugs
por: Lexchin, Joel, et al.
Publicado: (2014) -
Multinational Pharmaceutical Companies Shortchange Canada in Research and Development Investments: Is It Time to Pursue Other Options?
por: Lee, Shoo K., et al.
Publicado: (2023) -
The Pharmaceutical Industry and the Canadian Government: Folie à Deux
por: Lexchin, Joel
Publicado: (2017) -
Health Canada's Proposal to Accelerate New Drug Reviews
por: Lexchin, Joel
Publicado: (2020) -
Increase in Drug Spending in Canada Due to Extension of Data Protection for Biologics: A Descriptive Study
por: Lexchin, Joel
Publicado: (2019)